论文部分内容阅读
目的:探讨使用雷贝拉唑联用莫沙比利对慢性胃炎患者实施治疗的临床疗效.方法:选取本院(在2016年2月—2017年10月)收治的140例慢性胃炎患者作为研究对象,按照不同治疗方法随机分为实验组(应用克拉霉素、阿莫西林、雷贝拉唑联用莫沙比利治疗方法,70例)和对照组(应用奥美拉唑、克拉霉素联合阿莫西林治疗方法,70例).采用统计学分析两组慢性胃炎患者的临床治疗效果、Hp(幽门螺旋杆菌)根除率.结果:实验组慢性胃炎患者的治疗效果显著高于对照组(P＜0.05);实验组慢性胃炎患者的Hp根除率显著高于对照组(P＜0.05).结论:雷贝拉唑联用莫沙比利治疗慢性胃炎的临床疗效显著.","Objective To explore the clinical effect of using ray Bella azole in the treatment of chronic gastritis patients with Mosa Billy. Methods Select our hospital (in February 2016 May -2017) in 140 cases with chronic gastritis were treated as the research object, according to the different treatment methods were randomly divided into experimental group (Application of clarithromycin and amoxicillin, ray Bella with combined with Mosapride treatment, 70 cases) and control group (omeprazole, clarithromycin and amoxicillin treatment. 70 cases). The clinical curative effect of two groups of chronic gastritis patients and the eradication rate of Hp (Helicobacter pylori) were analyzed statistically. Results The treatment effect of chronic gastritis in the experimental group was significantly higher than that in the control group (P＜0.05), and the eradication rate of Hp in the experimental group was significantly higher than that in the control group (P＜0.05). Condusion The clinical efficacy of ray Bella azole combined with Mosa Billy in the treatment of chronic gastritis is significant